What is the present valuation and projected CAGR of the animal parasiticides market?
The animal parasiticides market size has grown strongly in recent years. It will grow from $9.39 billion in 2024 to $10.15 billion in 2025 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to disease outbreaks, livestock productivity concerns, rising pet ownership, government regulations, and advancements in veterinary medicine.
The animal parasiticides market size is expected to see strong growth in the next few years. It will grow to $13.69 billion in 2029 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to increasing zoonotic diseases, growth in companion animal population, expansion of livestock farming, innovation in parasiticide formulations, and rising awareness of animal health. Major trends in the forecast period include the development of long-acting formulations, advancement in biologics and vaccines, use of nanotechnology in drug delivery, precision dosing technologies, and digital tracking and monitoring systems.
Get Your Free Sample of The Global Animal Parasiticides Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21098&type=smp
What key drivers have fueled the animal parasiticides market’s development over the years?
The increase in the prevalence of zoonotic diseases is expected to propel the growth of the animal parasiticides market going forward. Zoonotic diseases are infectious diseases that can be transmitted between animals and humans caused by bacteria, viruses, parasites, or fungi. The number of zoonotic diseases is increasing due to factors including climate change, antibiotic resistance, poor sanitation, and hygiene. Animal parasiticides help prevent zoonotic diseases by controlling parasites that act as vectors or reservoirs for disease transmission between animals and humans. For instance, in April 2024, according to the European Centre for Disease Prevention and Control, a UK-based governmental organization, the number of confirmed brucellosis cases increased to 199 in 2022, from 165 cases in 2021. Therefore, the increase in the prevalence of zoonotic diseases is driving the growth of the animal parasiticides market.
What is the segmentation for the animal parasiticides market?
The animal parasiticides market covered in this report is segmented –
1) By Type: Endoparasticides, Ectoparasiticides, Endectocides
2) By Livestock: Swine, Poultry, Ovine, Bovine, Equine, Canine, Feline
3) By End User: Veterinary Clinics and Hospitals, Animal Farms, Home Care Settings
Subsegments:
1) By Endoparasiticides: Anthelmintics, Antiprotozoals, Anticestodals
2) By Ectoparasiticides: Insecticides, Acaricides, Larvicides
3) By Endectocides: Macrocyclic Lactones, Imidazothiazoles, Spinosyns
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/animal-parasiticides-global-market-report
Who are the most influential companies in the animal parasiticides market?
Major companies operating in the animal parasiticides market are Merck & Co. Inc., Bayer AG, Sanofi SA, Boehringer Ingelheim GmbH, Zoetis Inc., Elanco Animal Health Inc., Ceva Sante Animale S.A., Virbac SA, Dechra Pharmaceuticals plc, Phibro Animal Health Corporation, Vetoquinol SA, Norbrook Laboratories Limited, Neogen Corporation, Indian Immunologicals Ltd., Krka dd Novo Mesto, Bimeda Inc., The Chanelle Group, ECO Animal Health Group plc, Zydus Animal Health and Investments Ltd., Kyoritsu Seiyaku Corporation
What are the top industry trends projected to impact the animal parasiticides market?
Major companies operating in the animal parasiticides market are focused on developing innovative solutions, such as combination therapy, to enhance efficacy, broaden the spectrum of parasite control, reduce resistance development, and improve convenience and compliance for pet owners and livestock managers. Combination therapy involves using two or more active agents with different mechanisms of action to treat or prevent a disease, enhancing efficacy and reducing the risk of resistance. For instance, in January 2022, Zoetis Inc., a US-based animal health company, received FDA approval for a new label indication of Simparica Trio, recognizing its effectiveness in preventing Borrelia burgdorferi infections by targeting and eliminating Ixodes scapularis vector ticks. This innovative all-in-one chewable tablet offers broad-spectrum protection by effectively killing Ixodes scapularis ticks, the primary vectors of Lyme disease, before they can transmit the infection. Its triple-action formula provides comprehensive parasite control, targeting fleas, ticks, heartworms, roundworms, and hookworms in a single monthly dose.
What are the major regional insights for the animal parasiticides market, and which region holds the top position?
North America was the largest region in the animal parasiticides market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the animal parasiticides market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Animal Parasiticides Market Report 2025 Offer?
The animal parasiticides market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Animal parasiticides refer to chemical or biological agents designed to prevent, control, and eliminate parasitic infestations in livestock, companion animals, and other domesticated species. They are used for protecting animals from external and internal parasites, improving animal health, and enhancing productivity in agricultural and veterinary settings.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21098
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
